← Back
C

$ Value

Shares

131,578

Price

Filed

Aug 11

Insider

Name

BARABE TIMOTHY C

Title

CIK

0001237409

Roles

Director

Transaction Details

Transaction Date

2025-08-11

Code

C

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

168,357

Footnotes

Upon the closing of Heartflow, Inc.'s ("Heartflow") initial public offering, the convertible promissory notes automatically converted into shares of Heartflow's common stock at a conversion price of 80% of the price per share in Heartflow's initial public offering, subject to a valuation ceiling of $2.0 billion. The shares of common stock that were issuable upon conversion of the convertible promissory note had no expiration date. These shares are reported in Table II above on an as-converted basis. | The option will vest in full on the earlier of Heartflow's annual meeting of shareholders in 2026 and the first anniversary of the grant date, subject to continued service through such date.

Filing Info

Accession No.

0001628280-25-039731

Form Type

4

Issuer CIK

0001464521

BARABE TIMOTHY C's History

Date Ticker Type Value
2026-03-11 HTFL M $19K
2026-03-11 HTFL M $0
2026-02-17 HTFL M $21K
2026-02-17 HTFL M $0
2026-01-02 RNAC A $0
2026-01-02 RNAC A $0
2025-12-04 RNAC $206K
2025-08-11 HTFL C
2025-08-11 HTFL C $0
2025-08-07 HTFL A $0

Other Insiders at HTFL (90d)

Insider Bought Sold Last
BARABE TIMOTHY C 2026-03-11
HealthCor Partners Management LP 2026-03-24
Lightcap Jeffrey C 2026-03-24
Rogers Campbell
Chief Medical Officer
$4.8M 2026-04-01
Bain Capital Life Sciences Investors, LLC $56.1M 2026-02-04
Cullivan Julie A $447K 2026-03-05
Farquhar John C.M.
Chief Executive Officer
$1.8M 2026-04-10
Jones Marie L.
Chief Accounting Officer, VP
2026-02-06
Verghese Vikram
Chief Financial Officer
2026-02-06